Management of COVID-19: the Zhejiang experience

The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 in Zhejiang province....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban 2020-05, Vol.49 (2), p.147-157
Hauptverfasser: Xu, Kaijin, Cai, Hongliu, Shen, Yihong, Ni, Qin, Chen, Yu, Hu, Shaohua, Li, Jianping, Wang, Huafen, Yu, Liang, Huang, He, Qiu, Yunqing, Wei, Guoqing, Fang, Qiang, Zhou, Jianying, Sheng, Jifang, Liang, Tingbo, Li, Lanjuan
Format: Artikel
Sprache:chi
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 157
container_issue 2
container_start_page 147
container_title Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban
container_volume 49
creator Xu, Kaijin
Cai, Hongliu
Shen, Yihong
Ni, Qin
Chen, Yu
Hu, Shaohua
Li, Jianping
Wang, Huafen
Yu, Liang
Huang, He
Qiu, Yunqing
Wei, Guoqing
Fang, Qiang
Zhou, Jianying
Sheng, Jifang
Liang, Tingbo
Li, Lanjuan
description The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 in Zhejiang province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on "Four-Anti and Two-Balance" for clinical practice. The "Four-Anti and Two-Balance" strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinary personalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making. Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in 10%patients' blood samples at acute period and 50%of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifying cytokine storms and application of artificial liver blood purification system. The "Four-Anti and Two-Balance" strategy effectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviral effects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favored the balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short period of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center. Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strateg
doi_str_mv 10.3785/j.issn.1008-9292.2020.02.02
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2401092638</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2401092638</sourcerecordid><originalsourceid>FETCH-LOGICAL-c184t-f4723869ab7301421807ddf4feaccf0bdb75f55eaf6de6067b79c37a6c925c723</originalsourceid><addsrcrecordid>eNo9T01Lw0AU3INiS-1fkIAXL0nf7ma_vEn8KlR6UQ9ewmbztk3Jl9kU9N8bsMoMPBhm5jGEXFNIuNJidUiqENqEAujYMMMSBgwSYBPPyPxfnpFlCFUBgnI1AS7IjDNuqBR6TlYvtrU7bLAdo85H2fZ9fR9TcxuNe4w-9niobLuL8KvHocLW4SU597YOuDzdBXl7fHjNnuPN9mmd3W1iR3U6xj5VjGtpbDE9pCmjGlRZ-tSjdc5DURZKeCHQelmiBKkKZRxXVjrDhJuyC3Lz29sP3ecRw5g3VXBY17bF7hhylgIFwyTXk_XqZD0WDZZ5P1SNHb7zv5H8B8b_U20</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2401092638</pqid></control><display><type>article</type><title>Management of COVID-19: the Zhejiang experience</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Xu, Kaijin ; Cai, Hongliu ; Shen, Yihong ; Ni, Qin ; Chen, Yu ; Hu, Shaohua ; Li, Jianping ; Wang, Huafen ; Yu, Liang ; Huang, He ; Qiu, Yunqing ; Wei, Guoqing ; Fang, Qiang ; Zhou, Jianying ; Sheng, Jifang ; Liang, Tingbo ; Li, Lanjuan</creator><creatorcontrib>Xu, Kaijin ; Cai, Hongliu ; Shen, Yihong ; Ni, Qin ; Chen, Yu ; Hu, Shaohua ; Li, Jianping ; Wang, Huafen ; Yu, Liang ; Huang, He ; Qiu, Yunqing ; Wei, Guoqing ; Fang, Qiang ; Zhou, Jianying ; Sheng, Jifang ; Liang, Tingbo ; Li, Lanjuan</creatorcontrib><description>The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 in Zhejiang province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on "Four-Anti and Two-Balance" for clinical practice. The "Four-Anti and Two-Balance" strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinary personalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making. Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in 10%patients' blood samples at acute period and 50%of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifying cytokine storms and application of artificial liver blood purification system. The "Four-Anti and Two-Balance" strategy effectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviral effects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favored the balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short period of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center. Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strategies. Antimicrobial prophylaxis was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbial dysbiosis with decreased probiotics such as and , so nutritional and gastrointestinal function should be assessed for all patients.Nutritional support and application of prebiotics or probiotics were suggested to regulate the balance of intestinal microbiota and reduce the risk of secondary infection due to bacterial translocation. Anxiety and fear were common in patients with COVID-19. Therefore,we established dynamic assessment and warning for psychological crisis. We also integrated Chinese medicine in treatment to promote disease rehabilitation through classification methods of traditional Chinese medicine. We optimized nursing process for severe patients to promote their rehabilitation. It remained unclear about viral clearance pattern after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, two weeks' quarantine for discharged patients was required and a regular following up was also needed.The Zhejiang experience and suggestions have been implemented in our center and achieved good results. However, since COVID-19 was a newly emerging disease, more work was warranted to improve strategies of prevention, diagnosis and treatment for COVID-19.</description><identifier>ISSN: 1008-9292</identifier><identifier>DOI: 10.3785/j.issn.1008-9292.2020.02.02</identifier><identifier>PMID: 32391658</identifier><language>chi</language><publisher>China</publisher><subject>Betacoronavirus - isolation &amp; purification ; China - epidemiology ; Coronavirus Infections - diagnosis ; Coronavirus Infections - epidemiology ; Coronavirus Infections - therapy ; Coronavirus Infections - virology ; COVID-19 ; Disease Management ; Early Diagnosis ; Feces - virology ; Humans ; Pandemics ; Pneumonia, Viral - diagnosis ; Pneumonia, Viral - epidemiology ; Pneumonia, Viral - therapy ; Pneumonia, Viral - virology ; SARS-CoV-2 ; Sputum - virology</subject><ispartof>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban, 2020-05, Vol.49 (2), p.147-157</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c184t-f4723869ab7301421807ddf4feaccf0bdb75f55eaf6de6067b79c37a6c925c723</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32391658$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Kaijin</creatorcontrib><creatorcontrib>Cai, Hongliu</creatorcontrib><creatorcontrib>Shen, Yihong</creatorcontrib><creatorcontrib>Ni, Qin</creatorcontrib><creatorcontrib>Chen, Yu</creatorcontrib><creatorcontrib>Hu, Shaohua</creatorcontrib><creatorcontrib>Li, Jianping</creatorcontrib><creatorcontrib>Wang, Huafen</creatorcontrib><creatorcontrib>Yu, Liang</creatorcontrib><creatorcontrib>Huang, He</creatorcontrib><creatorcontrib>Qiu, Yunqing</creatorcontrib><creatorcontrib>Wei, Guoqing</creatorcontrib><creatorcontrib>Fang, Qiang</creatorcontrib><creatorcontrib>Zhou, Jianying</creatorcontrib><creatorcontrib>Sheng, Jifang</creatorcontrib><creatorcontrib>Liang, Tingbo</creatorcontrib><creatorcontrib>Li, Lanjuan</creatorcontrib><title>Management of COVID-19: the Zhejiang experience</title><title>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban</title><addtitle>Zhejiang Da Xue Xue Bao Yi Xue Ban</addtitle><description>The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 in Zhejiang province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on "Four-Anti and Two-Balance" for clinical practice. The "Four-Anti and Two-Balance" strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinary personalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making. Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in 10%patients' blood samples at acute period and 50%of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifying cytokine storms and application of artificial liver blood purification system. The "Four-Anti and Two-Balance" strategy effectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviral effects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favored the balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short period of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center. Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strategies. Antimicrobial prophylaxis was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbial dysbiosis with decreased probiotics such as and , so nutritional and gastrointestinal function should be assessed for all patients.Nutritional support and application of prebiotics or probiotics were suggested to regulate the balance of intestinal microbiota and reduce the risk of secondary infection due to bacterial translocation. Anxiety and fear were common in patients with COVID-19. Therefore,we established dynamic assessment and warning for psychological crisis. We also integrated Chinese medicine in treatment to promote disease rehabilitation through classification methods of traditional Chinese medicine. We optimized nursing process for severe patients to promote their rehabilitation. It remained unclear about viral clearance pattern after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, two weeks' quarantine for discharged patients was required and a regular following up was also needed.The Zhejiang experience and suggestions have been implemented in our center and achieved good results. However, since COVID-19 was a newly emerging disease, more work was warranted to improve strategies of prevention, diagnosis and treatment for COVID-19.</description><subject>Betacoronavirus - isolation &amp; purification</subject><subject>China - epidemiology</subject><subject>Coronavirus Infections - diagnosis</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Coronavirus Infections - therapy</subject><subject>Coronavirus Infections - virology</subject><subject>COVID-19</subject><subject>Disease Management</subject><subject>Early Diagnosis</subject><subject>Feces - virology</subject><subject>Humans</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - diagnosis</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Pneumonia, Viral - therapy</subject><subject>Pneumonia, Viral - virology</subject><subject>SARS-CoV-2</subject><subject>Sputum - virology</subject><issn>1008-9292</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9T01Lw0AU3INiS-1fkIAXL0nf7ma_vEn8KlR6UQ9ewmbztk3Jl9kU9N8bsMoMPBhm5jGEXFNIuNJidUiqENqEAujYMMMSBgwSYBPPyPxfnpFlCFUBgnI1AS7IjDNuqBR6TlYvtrU7bLAdo85H2fZ9fR9TcxuNe4w-9niobLuL8KvHocLW4SU597YOuDzdBXl7fHjNnuPN9mmd3W1iR3U6xj5VjGtpbDE9pCmjGlRZ-tSjdc5DURZKeCHQelmiBKkKZRxXVjrDhJuyC3Lz29sP3ecRw5g3VXBY17bF7hhylgIFwyTXk_XqZD0WDZZ5P1SNHb7zv5H8B8b_U20</recordid><startdate>20200525</startdate><enddate>20200525</enddate><creator>Xu, Kaijin</creator><creator>Cai, Hongliu</creator><creator>Shen, Yihong</creator><creator>Ni, Qin</creator><creator>Chen, Yu</creator><creator>Hu, Shaohua</creator><creator>Li, Jianping</creator><creator>Wang, Huafen</creator><creator>Yu, Liang</creator><creator>Huang, He</creator><creator>Qiu, Yunqing</creator><creator>Wei, Guoqing</creator><creator>Fang, Qiang</creator><creator>Zhou, Jianying</creator><creator>Sheng, Jifang</creator><creator>Liang, Tingbo</creator><creator>Li, Lanjuan</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20200525</creationdate><title>Management of COVID-19: the Zhejiang experience</title><author>Xu, Kaijin ; Cai, Hongliu ; Shen, Yihong ; Ni, Qin ; Chen, Yu ; Hu, Shaohua ; Li, Jianping ; Wang, Huafen ; Yu, Liang ; Huang, He ; Qiu, Yunqing ; Wei, Guoqing ; Fang, Qiang ; Zhou, Jianying ; Sheng, Jifang ; Liang, Tingbo ; Li, Lanjuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c184t-f4723869ab7301421807ddf4feaccf0bdb75f55eaf6de6067b79c37a6c925c723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2020</creationdate><topic>Betacoronavirus - isolation &amp; purification</topic><topic>China - epidemiology</topic><topic>Coronavirus Infections - diagnosis</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Coronavirus Infections - therapy</topic><topic>Coronavirus Infections - virology</topic><topic>COVID-19</topic><topic>Disease Management</topic><topic>Early Diagnosis</topic><topic>Feces - virology</topic><topic>Humans</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - diagnosis</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Pneumonia, Viral - therapy</topic><topic>Pneumonia, Viral - virology</topic><topic>SARS-CoV-2</topic><topic>Sputum - virology</topic><toplevel>online_resources</toplevel><creatorcontrib>Xu, Kaijin</creatorcontrib><creatorcontrib>Cai, Hongliu</creatorcontrib><creatorcontrib>Shen, Yihong</creatorcontrib><creatorcontrib>Ni, Qin</creatorcontrib><creatorcontrib>Chen, Yu</creatorcontrib><creatorcontrib>Hu, Shaohua</creatorcontrib><creatorcontrib>Li, Jianping</creatorcontrib><creatorcontrib>Wang, Huafen</creatorcontrib><creatorcontrib>Yu, Liang</creatorcontrib><creatorcontrib>Huang, He</creatorcontrib><creatorcontrib>Qiu, Yunqing</creatorcontrib><creatorcontrib>Wei, Guoqing</creatorcontrib><creatorcontrib>Fang, Qiang</creatorcontrib><creatorcontrib>Zhou, Jianying</creatorcontrib><creatorcontrib>Sheng, Jifang</creatorcontrib><creatorcontrib>Liang, Tingbo</creatorcontrib><creatorcontrib>Li, Lanjuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Kaijin</au><au>Cai, Hongliu</au><au>Shen, Yihong</au><au>Ni, Qin</au><au>Chen, Yu</au><au>Hu, Shaohua</au><au>Li, Jianping</au><au>Wang, Huafen</au><au>Yu, Liang</au><au>Huang, He</au><au>Qiu, Yunqing</au><au>Wei, Guoqing</au><au>Fang, Qiang</au><au>Zhou, Jianying</au><au>Sheng, Jifang</au><au>Liang, Tingbo</au><au>Li, Lanjuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of COVID-19: the Zhejiang experience</atitle><jtitle>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban</jtitle><addtitle>Zhejiang Da Xue Xue Bao Yi Xue Ban</addtitle><date>2020-05-25</date><risdate>2020</risdate><volume>49</volume><issue>2</issue><spage>147</spage><epage>157</epage><pages>147-157</pages><issn>1008-9292</issn><abstract>The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 in Zhejiang province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on "Four-Anti and Two-Balance" for clinical practice. The "Four-Anti and Two-Balance" strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinary personalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making. Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in 10%patients' blood samples at acute period and 50%of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifying cytokine storms and application of artificial liver blood purification system. The "Four-Anti and Two-Balance" strategy effectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviral effects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favored the balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short period of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center. Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strategies. Antimicrobial prophylaxis was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbial dysbiosis with decreased probiotics such as and , so nutritional and gastrointestinal function should be assessed for all patients.Nutritional support and application of prebiotics or probiotics were suggested to regulate the balance of intestinal microbiota and reduce the risk of secondary infection due to bacterial translocation. Anxiety and fear were common in patients with COVID-19. Therefore,we established dynamic assessment and warning for psychological crisis. We also integrated Chinese medicine in treatment to promote disease rehabilitation through classification methods of traditional Chinese medicine. We optimized nursing process for severe patients to promote their rehabilitation. It remained unclear about viral clearance pattern after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, two weeks' quarantine for discharged patients was required and a regular following up was also needed.The Zhejiang experience and suggestions have been implemented in our center and achieved good results. However, since COVID-19 was a newly emerging disease, more work was warranted to improve strategies of prevention, diagnosis and treatment for COVID-19.</abstract><cop>China</cop><pmid>32391658</pmid><doi>10.3785/j.issn.1008-9292.2020.02.02</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1008-9292
ispartof Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban, 2020-05, Vol.49 (2), p.147-157
issn 1008-9292
language chi
recordid cdi_proquest_miscellaneous_2401092638
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Betacoronavirus - isolation & purification
China - epidemiology
Coronavirus Infections - diagnosis
Coronavirus Infections - epidemiology
Coronavirus Infections - therapy
Coronavirus Infections - virology
COVID-19
Disease Management
Early Diagnosis
Feces - virology
Humans
Pandemics
Pneumonia, Viral - diagnosis
Pneumonia, Viral - epidemiology
Pneumonia, Viral - therapy
Pneumonia, Viral - virology
SARS-CoV-2
Sputum - virology
title Management of COVID-19: the Zhejiang experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T12%3A43%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20COVID-19:%20the%20Zhejiang%20experience&rft.jtitle=Zhejiang%20da%20xue%20xue%20bao.%20Journal%20of%20Zhejiang%20University.%20Medical%20sciences.%20Yi%20xue%20ban&rft.au=Xu,%20Kaijin&rft.date=2020-05-25&rft.volume=49&rft.issue=2&rft.spage=147&rft.epage=157&rft.pages=147-157&rft.issn=1008-9292&rft_id=info:doi/10.3785/j.issn.1008-9292.2020.02.02&rft_dat=%3Cproquest_pubme%3E2401092638%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2401092638&rft_id=info:pmid/32391658&rfr_iscdi=true